Sorry! This page doesn't exist anymore
Interested in attending our upcoming events? Reach out to us to get more information.
FDA Roadmap: From Designation to Approval
Effectively engaging with the FDA is a critical step for any innovator to bring a life-science product to market. Led by Laura Rose, this session will demystify the FDA, help you map your regulatory path to market, and explore partnerships with Contract Research Organizations (CROs).
Topics include:
Decision framework for engaging the FDA
FDA’s structure and how to determine the correct office for your product
Regulatory-ready basics of product development
How to identify and work with CROs and the role of CMC
Best practices for balancing publicizing research with regulatory approval requirements
Laura Rose
Consultant and Ex-FDA
SEMINAR SPEAKER
Laura Rose, PhD, is a biomedical engineer with deep expertise in FDA regulatory pathways for medical devices and combination products. Before joining Bruder Consulting Venture Group, she spent nearly eight years at FDA, most recently as Assistant Director in CDRH’s Office of Orthopedic Devices, where she led multidisciplinary teams and collaborated extensively with CBER and CDER. Laura brings a practical, strategic approach to regulatory problem-solving and has a strong background in tissue engineering, regenerative medicine, and cell therapy.
November 6, 2025 | 12:00 PM-1:00 PM
In-Person Attendance: JHTV - 1812 Ashland Ave, Baltimore, MD 21205
(lunch will be provided to those attending in person)
Virtual Attendance: Zoom (a link will be provided upon registration)
Office Hours: Laura Rose has offered to host 20-minute in person office hours following the seminar for individuals who have specific questions or would like to dig a little deeper. These are offered on a first come, first serve basis and must be scheduled in advance. Please email Alex Voss, avoss1@jh.edu if you are interested in scheduling office hours.